Don't forget to register for the seminar on An overview of the Phase 1 Trial of TPI-287/Temezolomide in Neuroblastoma and Medulloblastoma tomorrow. Dr. Giselle Sholler, principal investigator and pediatric oncologist from Vermont Cancer Center, will be presenting important information regarding the...